Description

Tamoxifen

Selective Estrogen Receptor Modulator (SERM) Research Compound

Tamoxifen is a well-characterized selective estrogen receptor modulator (SERM) extensively studied for its ability to influence estrogen receptor signaling in a tissue-dependent manner.

Unlike aromatase inhibitors, which reduce estrogen synthesis, tamoxifen primarily acts by binding to estrogen receptors and modifying their activity. This unique mechanism has made tamoxifen an important compound in endocrine, estrogen-receptor, and hormone-responsive cellular research.

How Tamoxifen Works

Tamoxifen and its active metabolites interact primarily with estrogen receptors ERα and ERβ. Depending on the tissue and biological environment, these interactions can produce either estrogen-antagonistic or estrogen-agonistic activity.

Tamoxifen’s pharmacological activity is influenced by active metabolites including 4-hydroxytamoxifen and endoxifen, which possess strong affinity for estrogen receptors.

Research involving tamoxifen commonly examines:

• Estrogen receptor modulation
• ERα and ERβ signaling
• Estrogen-responsive gene expression
• Endocrine signaling
• Hormone-responsive cellular pathways
• Selective estrogen receptor pharmacology

Key Characteristics

Selective Estrogen Receptor Modulation
Tamoxifen does not simply eliminate estrogen activity. Instead, it can block or mimic certain estrogenic effects depending on the target tissue.

Well-Characterized SERM
Tamoxifen is one of the most extensively studied selective estrogen receptor modulators, with decades of clinical and laboratory research.

Active Metabolites
Tamoxifen undergoes hepatic metabolism into several metabolites, including endoxifen and 4-hydroxytamoxifen, which contribute significantly to its estrogen-receptor activity.

Extended Pharmacological Profile
Tamoxifen and its metabolites have relatively long elimination profiles, allowing estrogen-receptor modulation to persist after administration.

Research Areas

Tamoxifen has been investigated in research involving:

• Estrogen receptor signaling
• ERα and ERβ pharmacology
• Estrogen-responsive gene expression
• Hormone-responsive cellular biology
• Breast cancer biology
• Endocrine signaling
• Reproductive physiology
• SERM pharmacology
• Tamoxifen metabolism
• CYP2D6-mediated formation of active metabolites

Compound Information

Compound: Tamoxifen
Compound Class: Selective Estrogen Receptor Modulator (SERM)
Molecular Formula: C₂₆H₂₉NO
Molecular Weight: 371.52 g/mol
Approximate Terminal Half-Life: 5–7 days for tamoxifen, with some metabolites persisting longer
Primary Targets: Estrogen Receptors ERα and ERβ

Tamoxifen vs. Aromatase Inhibitors

Tamoxifen differs fundamentally from aromatase inhibitors such as anastrozole and letrozole.

Aromatase inhibitors suppress the enzymatic production of estrogen, whereas tamoxifen modulates estrogen receptor activity without directly inhibiting aromatase.

This distinction makes these compounds useful for studying different points within estrogen-dependent signaling pathways.

Notice & Acknowledgement